Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Inventory (2020 - 2025)

Maravai Lifesciences Holdings has reported Inventory over the past 6 years, most recently at $40.5 million for Q4 2025.

  • Quarterly results put Inventory at $40.5 million for Q4 2025, down 19.14% from a year ago — trailing twelve months through Dec 2025 was $40.5 million (down 19.14% YoY), and the annual figure for FY2025 was $40.5 million, down 19.14%.
  • Inventory for Q4 2025 was $40.5 million at Maravai Lifesciences Holdings, down from $45.3 million in the prior quarter.
  • Over the last five years, Inventory for MRVI hit a ceiling of $62.4 million in Q3 2022 and a floor of $40.5 million in Q4 2025.
  • Median Inventory over the past 5 years was $49.8 million (2024), compared with a mean of $50.2 million.
  • Biggest five-year swings in Inventory: skyrocketed 54.82% in 2021 and later dropped 21.28% in 2023.
  • Maravai Lifesciences Holdings' Inventory stood at $51.6 million in 2021, then decreased by 16.3% to $43.2 million in 2022, then increased by 19.11% to $51.4 million in 2023, then dropped by 2.56% to $50.1 million in 2024, then dropped by 19.14% to $40.5 million in 2025.
  • The last three reported values for Inventory were $40.5 million (Q4 2025), $45.3 million (Q3 2025), and $46.7 million (Q2 2025) per Business Quant data.